Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Gummer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Respirology (Carlton, Vic.)|March 26, 2019
Metabolomics in chronic lung diseasesShabarinath Nambiar, Sze Bong How, Joel Gummer, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 13, 2016
Dysregulated Erythropoietin, Hepcidin, and Bone Marrow Iron Metabolism Contribute to Interferon-Induced Anemia in Hepatitis CMarius van Rijnsoever, Sumedha Galhenage, Lindsay Mollison, et al.
Nephrology (Carlton, Vic.)|October 25, 2011
Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney diseaseHayley Abbiss, Garth L Maker, Joel Gummer, et al.
Eukaryotic Cell|May 25, 2010
The transcription factor StuA regulates central carbon metabolism, mycotoxin production, and effector gene expression in the wheat pathogen Stagonospora nodorumSimon V S IpCho, Kar-Chun Tan, Geraldine Koh, et al.
Proteomics. Clinical Applications|February 13, 2021
Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosisShabarinath Nambiar, Dino Bee Aik Tan, Britt Clynick, et al.
Hepatology Communications|June 9, 2018
Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver diseaseLaurence Britton, Kim Bridle, Janske Reiling, et al.
Journal of Intensive Care|September 15, 2018
Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort studyEdward Litton, Stuart Baker, Wendy Erber, et al.
Intensive Care Medicine|October 1, 2016
Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness, Edward Litton, Stuart Baker, et al.
Nephrology (Carlton, Vic.)|May 13, 2016
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialJoel Gummer, Robert Trengove, Elaine M Pascoe, et al.
BMJ Open|June 23, 2020
Study protocol for the safety and efficacy of probiotic therapy on days alive and out of hospital in adult ICU patients: the multicentre, randomised, placebo-controlled Restoration Of gut microflora in Critical Illness Trial (ROCIT)Edward Litton, Matthew Anstey, David Broadhurst, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Respirology (Carlton, Vic.)|March 26, 2019
Metabolomics in chronic lung diseasesShabarinath Nambiar, Sze Bong How, Joel Gummer, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 13, 2016
Dysregulated Erythropoietin, Hepcidin, and Bone Marrow Iron Metabolism Contribute to Interferon-Induced Anemia in Hepatitis CMarius van Rijnsoever, Sumedha Galhenage, Lindsay Mollison, et al.
Nephrology (Carlton, Vic.)|October 25, 2011
Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney diseaseHayley Abbiss, Garth L Maker, Joel Gummer, et al.
Eukaryotic Cell|May 25, 2010
The transcription factor StuA regulates central carbon metabolism, mycotoxin production, and effector gene expression in the wheat pathogen Stagonospora nodorumSimon V S IpCho, Kar-Chun Tan, Geraldine Koh, et al.
Proteomics. Clinical Applications|February 13, 2021
Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosisShabarinath Nambiar, Dino Bee Aik Tan, Britt Clynick, et al.
Hepatology Communications|June 9, 2018
Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver diseaseLaurence Britton, Kim Bridle, Janske Reiling, et al.
Journal of Intensive Care|September 15, 2018
Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort studyEdward Litton, Stuart Baker, Wendy Erber, et al.
Intensive Care Medicine|October 1, 2016
Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness, Edward Litton, Stuart Baker, et al.
Nephrology (Carlton, Vic.)|May 13, 2016
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialJoel Gummer, Robert Trengove, Elaine M Pascoe, et al.
BMJ Open|June 23, 2020
Study protocol for the safety and efficacy of probiotic therapy on days alive and out of hospital in adult ICU patients: the multicentre, randomised, placebo-controlled Restoration Of gut microflora in Critical Illness Trial (ROCIT)Edward Litton, Matthew Anstey, David Broadhurst, et al.
Pageof 2